Varian Medical Systems Inc gives Q2 2016 guidance; updates FY 2016 EPS guidance; reaffirms FY 2016 revenue guidance
Varian Medical Systems Inc:Including effects of R&D tax credit re-enactment and suspension of medical device excise tax in U.S., co believe that for FY 2016 total company non-GAAP earnings will be in the range of $4.55 to $4.65 per diluted share.Continues to expect that revenues for Fy 2016 will increase by about 4 to 5 percent over FY 2015.Says For Q2 2016, expect revenues to be up one to two percent from the year-ago quarter in dollars.expect non-GAAP earnings for Q2 2016 to be in the range of $1.06 to $1.10 per diluted share.
Latest Developments forVarian Medical Systems Inc
- Varian Medical Systems signs brachytherapy applicator distribution agreement with Bionix Radiation Therapy
- Varian sees Q4 non-GAAP earnings per share $1.15-$1.23 from continuing operations
- Varian Medical Systems Q3 non-GAAP earnings of $1.04 per share
- Varian Medical signs agreement with Vijametech and UPMC